[go: up one dir, main page]

FR2928371B1 - Derive de cysteine. - Google Patents

Derive de cysteine.

Info

Publication number
FR2928371B1
FR2928371B1 FR0951288A FR0951288A FR2928371B1 FR 2928371 B1 FR2928371 B1 FR 2928371B1 FR 0951288 A FR0951288 A FR 0951288A FR 0951288 A FR0951288 A FR 0951288A FR 2928371 B1 FR2928371 B1 FR 2928371B1
Authority
FR
France
Prior art keywords
cysteine derivative
cysteine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0951288A
Other languages
English (en)
Other versions
FR2928371A1 (fr
Inventor
Eko Suzuki
Keiji Iwasaki
Yoshinobu Takino
Fumie Futaki
Yusuke Amino
Fumie Okura
Megumi Kaneko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of FR2928371A1 publication Critical patent/FR2928371A1/fr
Application granted granted Critical
Publication of FR2928371B1 publication Critical patent/FR2928371B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0951288A 2008-02-28 2009-02-27 Derive de cysteine. Active FR2928371B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008047718 2008-02-28

Publications (2)

Publication Number Publication Date
FR2928371A1 FR2928371A1 (fr) 2009-09-11
FR2928371B1 true FR2928371B1 (fr) 2015-06-05

Family

ID=40981902

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0951288A Active FR2928371B1 (fr) 2008-02-28 2009-02-27 Derive de cysteine.

Country Status (2)

Country Link
JP (1) JP5439849B2 (fr)
FR (1) FR2928371B1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物
FR2958845B1 (fr) * 2010-04-16 2012-06-01 Clc Technologie Nouvelles compositions depigmentantes
WO2011149093A1 (fr) * 2010-05-28 2011-12-01 味の素株式会社 Dérivé de cystéine
JP5979154B2 (ja) * 2011-11-30 2016-08-24 味の素株式会社 システイン誘導体および界面活性剤を含有する化粧料
WO2013081146A1 (fr) * 2011-11-30 2013-06-06 味の素株式会社 Produit cosmétique antirides
WO2013081147A1 (fr) 2011-11-30 2013-06-06 味の素株式会社 Produit cosmétique de blanchiment de la peau
JP5979155B2 (ja) * 2011-11-30 2016-08-24 味の素株式会社 システイン誘導体およびアルコールを含有する化粧料
EP3603611B1 (fr) 2017-03-24 2024-01-10 Ajinomoto Co., Inc. Agent de blanchiment de la peau comprenant des acides aminés d spécifiques
EP3603612A4 (fr) 2017-03-24 2020-08-12 Ajinomoto Co., Inc. Agent améliorant les fonctions de la couche cornée
JPWO2021187411A1 (fr) * 2020-03-16 2021-09-23
WO2022250348A1 (fr) * 2021-05-26 2022-12-01 경북대학교 산학협력단 Utilisation de dérivé de cystéine pour le blanchiment de la peau
CN115138482B (zh) * 2022-07-06 2024-01-23 中南大学 一种黄铜矿和/或黄铁矿的靶向抑制及Cu-Fe-Mo硫化矿浮选分离方法
WO2025109193A1 (fr) * 2023-11-24 2025-05-30 Sanofi Thiazolidines synthétisées en tant que moyen de distribution de cystéine dans un flux d'alimentation de culture cellulaire

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759770A (fr) * 1969-12-19 1971-05-17 Houde Lab Composition therapeutique a base de produits de condensation d'esters d'acide glyoxylique avec des aminothiols et procede de preparation de ces produits de condensation
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
JP2000256131A (ja) * 1999-03-09 2000-09-19 Kose Corp チロシナーゼ生成抑制剤及びこれを含有する皮膚外用剤
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
JP2006315962A (ja) * 2005-05-10 2006-11-24 Geo Co Ltd システイン含有水性組成物

Also Published As

Publication number Publication date
JP5439849B2 (ja) 2014-03-12
FR2928371A1 (fr) 2009-09-11
JP2009227660A (ja) 2009-10-08

Similar Documents

Publication Publication Date Title
FR24C1047I2 (fr) Derive de 4-pyrimidinesulfamide
NO2021006I1 (no) Quofenix, delafloksacin
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
EP2376493A4 (fr) Dérivé de dihydropyrimidopyrimidine
EP2380877A4 (fr) Dérivé de pyridine-3-carboxyamide
FR2928371B1 (fr) Derive de cysteine.
DK2308877T3 (da) Imidazopyridin-2-on-derivater
HRP20151058T1 (xx) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
BRPI0915064A2 (pt) derivados de qunoxalinadiona
EP2344471A4 (fr) Dérivé de 7-pipéridinoalkyle-3,4-dihydroquinolone
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
IT1392848B1 (it) Motociclo.
EP2336132A4 (fr) Dérivé de morpholinopurine
UY33125A (es) Diaza-espiro-[5,5]-undecanos
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
DK2275414T3 (da) Cyclopentylacrylamidderivat
BRPI0907108A2 (pt) escova de dentes.
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0906714A2 (pt) Derivados de oxazepinopirimidona heteroarilamida substituídos.
BRPI0922652A2 (pt) Derivados de quinazolinamida
IT1393579B1 (it) Motociclo.
BRPI1016192A2 (pt) derivados de soxazol.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17